BROOKHAVEN NATIONAL LABORATORY

Overview

BROOKHAVEN NATIONAL LABORATORY is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering ACTINIUM-225 NITRATE.

API / Drug Master Files

BROOKHAVEN NATIONAL LABORATORY holds 1 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ACTINIUM-225 NITRATEActive2023-12-22
• CU-67 BULK RADIOISOTOPIC PRODUCTInactive1996-02-14
• STRONTIUM-82Inactive1984-07-23

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to BROOKHAVEN NATIONAL LABORATORY in our records. PharmaTek screens the full directory against live FDA enforcement data.